Inderal LA (propranolol hydrochloride) NDC 62559-521

NDC codes

FDA NDC Directory

Product NDC (as listed)62559-521Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62559-0521Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62559-521-01	62559052101	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-521-01)Marketed from Apr 28, 2017
62559-521-30	62559052130	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-521-30)Marketed from Aug 5, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Inderal LASuffix: LA
Generic name (nonproprietary): propranolol hydrochloride
Active ingredients: Propranolol hydrochloride — 80 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018553
Marketing start: Apr 28, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 62559-521_fd4ca726-c6f1-4fe6-b4b7-63a13f4944f7SPL ID fd4ca726-c6f1-4fe6-b4b7-63a13f4944f7SPL set ID 35d28979-36b1-4630-b85e-a44e0a443734RxCUI 856460, 856462, 856481, 856483, 856535, 856537, 856569, 856571UNII F8A3652H1VUPC 0362559521017, 0362559523011, 0362559522014, 0362559520010
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462559052101 followed by a unit qualifier and the quantity

Package 62559-0521-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 24, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hypertension Inderal LA is indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Inderal LA is not indicated in the management of hypertensive emergencies. Angina Pectoris Due to Coronary Atherosclerosis Inderal LA is indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Migraine Inderal LA is indicated for the prophylaxis of common migraine headache. The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. Hypertrophic…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 018553

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018553
Product	Strength	Form · route	Labeler	Product NDC
Inderal LApropranolol hydrochloride	Propranolol hydrochloride 60 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-520
Inderal LApropranolol hydrochloride	Propranolol hydrochloride 120 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-522
Inderal LApropranolol hydrochloride	Propranolol hydrochloride 160 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-523
Propranolol Hydrochloride ERpropranolol hydrochloride	Propranolol hydrochloride 60 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-530
Propranolol Hydrochloride ERpropranolol hydrochloride	Propranolol hydrochloride 160 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-533
Propranolol Hydrochloride ERpropranolol hydrochloride	Propranolol hydrochloride 80 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-531
Propranolol Hydrochloride ERpropranolol hydrochloride	Propranolol hydrochloride 120 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-532